| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_be41f0199bbb9b320c9597a75d14147a |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6845
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-71 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57415 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 |
| filingDate |
2017-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2aa75de93bdd25b0a8d9f4b153432bcc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c50b6b3632afbd9d775f2414d2e4ca77
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d7cd185b9fb8ca7eac5afc66db0f1754 |
| publicationDate |
2018-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CA-3009990-A1 |
| titleOfInvention |
Method for determining levels of her2/cb2 heteromer expression and uses in the treatment of a subject |
| abstract |
The invention generally relates to diagnostic, prognostic and monitoring methods and assays for breast cancer and kits that may be used in such methods. More particularly, the invention relates to a method of prognosis of a patient afflicted with breast cancer, comprising; determining the level of HER2/CB2 heteromer expression in a biological sample obtained from said patient. |
| priorityDate |
2016-10-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |